Join
Live feed
·
PRReleasevia Quantisnow
Vascular Biogenics Ltd. logo

VBL Therapeutics to Report First Quarter 2022 Financial Results on May 17

ByQuantisnow·Wall Street's wire, on your screen.
VBLT· Vascular Biogenics Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VBLT (Vascular Biogenics Ltd.) and more on Quantisnow.